Abstract:Background: The bone–vascular axis plays a key role in the pathogenesis of vascular calcification in patients with chronic kidney disease (CKD). Understanding and managing the role of the bone–vascular axis in chronic kidney disease–mineral and bone disorder is critical for preventing and treating associated complications, including osteoporosis, arterial calcification, and cardiovascular diseases. This study aimed to comprehensively summarize the role of bone metabolism markers in uremic vascular calcification. Summary: The skeleton, as an endocrine organ, can regulate systemic metabolic processes by secreting various bioactive substances. These molecules can induce the transdifferentiation of vascular smooth muscle cells, promoting their transition to other functional states, thereby affecting vascular growth and remodeling. Key Messages: The prevalence of vascular calcification in individuals with CKD is notably high. CKD-associated vascular calcification is characterized by the widespread accumulation of hydroxyapatite within the arterial media, which occurs as a result of the transformation of smooth muscle cells into osteoblastic smooth muscle cells under the influence of uremic toxins. Osteoblasts and osteoclasts in bone tissue secrete mineral metabolic proteins, which can influence neighboring cells, primarily vascular smooth muscle cells, through paracrine signaling. Both circulating and osteocytic sclerostin can exert a protective effect by inhibiting WNT-induced calcification. the therapeutic goal for CKD-MBD is to reduce production of sclerostin by decreasing the osteogenic transdifferentiation of vascular smooth muscle cells. Calciprotein particles act as a physiological agent for delivering calcium-phosphate the bone and inducing fibroblast growth factor-23 expression in osteoblasts.

Bone Morphogenetic Proteins and Vascular Calcification of End Stage Renal Disease

Key regulators of vascular calcification in chronic kidney disease: Hyperphosphatemia, BMP2, and RUNX2

The Role of Extracellular Vesicles in Vascular Calcification in Chronic Kidney Disease

Vascular Calcification: New Insights Into BMP Type I Receptor A

The Bone-Vascular Axis: A Key Player in Chronic Kidney Disease Associated Vascular Calcification

[Vascular Calcification - Pathological Mechanism and Clinical Application - . Role of vascular smooth muscle cells in vascular calcification]

[Extracellular Matrix, Matrix-Degrading Proteases and Vascular Calcification].

Bioinformatics analysis of key genes and potential therapeutic agents for vascular calcification in chronic kidney disease

Vascular Derived ECM Improves Therapeutic Index of BMP-2 and Drives Vascularized Bone Regeneration.

The role and mechanism of protein post‑translational modification in vascular calcification (Review)

Current Understanding of Cardiovascular Calcification in Patients with Chronic Kidney Disease

Pathogenesis and Mechanism of Uremic Vascular Calcification

Activation of Arterial Matrix Metalloproteinases Leads to Vascular Calcification in Chronic Kidney Disease

CCAAT/Enhancer-Binding Protein Alpha Is a Novel Regulator of Vascular Smooth Muscle Cell Osteochondrogenic Transition and Vascular Calcification

Bone Morphogenetic Proteins in Vascular Homeostasis and Disease

[The Mechanisms of High-Phosphate-induced Vascular Calcification in Patients with Chronic Kidney Disease].

Mechanisms of the Osteogenic Switch of Smooth Muscle Cells in Vascular Calcification: WNT Signaling, BMPs, Mechanotransduction, and EndMT

Advances in the mechanisms of vascular calcification in chronic kidney disease

BMP Signaling in Vascular Diseases

New Insights to the Crosstalk between Vascular and Bone Tissue in Chronic Kidney Disease–Mineral and Bone Disorder

[Bone metabolism and cardiovascular function Update. Vascular calcification as a manifestation of bone-vascular axis]